acid plus sham operation Search Results


99
Zymo Research quick dna miniprep plus kit
Quick Dna Miniprep Plus Kit, supplied by Zymo Research, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quick dna miniprep plus kit/product/Zymo Research
Average 99 stars, based on 1 article reviews
quick dna miniprep plus kit - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

96
Welcony rapid 2 transcranial magnetic stimulator
Rapid 2 Transcranial Magnetic Stimulator, supplied by Welcony, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rapid 2 transcranial magnetic stimulator/product/Welcony
Average 96 stars, based on 1 article reviews
rapid 2 transcranial magnetic stimulator - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
LKT Laboratories cepharanthine
Cepharanthine, supplied by LKT Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cepharanthine/product/LKT Laboratories
Average 90 stars, based on 1 article reviews
cepharanthine - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Galectin Therapeutics n-acetyllactosamine
Representative immunohistochemistry of galectin-3 protein expression in hearts (×200). (A) Sham. (B) BDL. (C) BDL+N-Lac. (D) Spleen was used as positive control. (A) Scant staining is visible in cardiomyocytes. (B) Significantly increased galectin-3 staining is predominantly in cardiomyocyte cytoplasm, although a few macrophages also stain. (C) N-Lac significantly decreased galectin-3 staining in BDL heart. N-Lac did not affect galectin-3 postive staining in heart from sham operated controls (data not shown). (D) Spleen shows expected heavy galectin-3 staining, as a positive control. Sham, sham operated; BDL, bile duct ligation; N-Lac, N <t>-acetyllactosamine.</t>
N Acetyllactosamine, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n-acetyllactosamine/product/Galectin Therapeutics
Average 90 stars, based on 1 article reviews
n-acetyllactosamine - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
New England Nuclear Corporation genescreen plus
Representative immunohistochemistry of galectin-3 protein expression in hearts (×200). (A) Sham. (B) BDL. (C) BDL+N-Lac. (D) Spleen was used as positive control. (A) Scant staining is visible in cardiomyocytes. (B) Significantly increased galectin-3 staining is predominantly in cardiomyocyte cytoplasm, although a few macrophages also stain. (C) N-Lac significantly decreased galectin-3 staining in BDL heart. N-Lac did not affect galectin-3 postive staining in heart from sham operated controls (data not shown). (D) Spleen shows expected heavy galectin-3 staining, as a positive control. Sham, sham operated; BDL, bile duct ligation; N-Lac, N <t>-acetyllactosamine.</t>
Genescreen Plus, supplied by New England Nuclear Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genescreen plus/product/New England Nuclear Corporation
Average 90 stars, based on 1 article reviews
genescreen plus - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dawley Inc sprague–dawley rats
Representative immunohistochemistry of galectin-3 protein expression in hearts (×200). (A) Sham. (B) BDL. (C) BDL+N-Lac. (D) Spleen was used as positive control. (A) Scant staining is visible in cardiomyocytes. (B) Significantly increased galectin-3 staining is predominantly in cardiomyocyte cytoplasm, although a few macrophages also stain. (C) N-Lac significantly decreased galectin-3 staining in BDL heart. N-Lac did not affect galectin-3 postive staining in heart from sham operated controls (data not shown). (D) Spleen shows expected heavy galectin-3 staining, as a positive control. Sham, sham operated; BDL, bile duct ligation; N-Lac, N <t>-acetyllactosamine.</t>
Sprague–Dawley Rats, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sprague–dawley rats/product/Dawley Inc
Average 90 stars, based on 1 article reviews
sprague–dawley rats - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Jackson Laboratory balb/c mice
Representative immunohistochemistry of galectin-3 protein expression in hearts (×200). (A) Sham. (B) BDL. (C) BDL+N-Lac. (D) Spleen was used as positive control. (A) Scant staining is visible in cardiomyocytes. (B) Significantly increased galectin-3 staining is predominantly in cardiomyocyte cytoplasm, although a few macrophages also stain. (C) N-Lac significantly decreased galectin-3 staining in BDL heart. N-Lac did not affect galectin-3 postive staining in heart from sham operated controls (data not shown). (D) Spleen shows expected heavy galectin-3 staining, as a positive control. Sham, sham operated; BDL, bile duct ligation; N-Lac, N <t>-acetyllactosamine.</t>
Balb/C Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/balb/c mice/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
balb/c mice - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Illumina Inc stranded total rna plus ribo-zero kits
Representative immunohistochemistry of galectin-3 protein expression in hearts (×200). (A) Sham. (B) BDL. (C) BDL+N-Lac. (D) Spleen was used as positive control. (A) Scant staining is visible in cardiomyocytes. (B) Significantly increased galectin-3 staining is predominantly in cardiomyocyte cytoplasm, although a few macrophages also stain. (C) N-Lac significantly decreased galectin-3 staining in BDL heart. N-Lac did not affect galectin-3 postive staining in heart from sham operated controls (data not shown). (D) Spleen shows expected heavy galectin-3 staining, as a positive control. Sham, sham operated; BDL, bile duct ligation; N-Lac, N <t>-acetyllactosamine.</t>
Stranded Total Rna Plus Ribo Zero Kits, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stranded total rna plus ribo-zero kits/product/Illumina Inc
Average 90 stars, based on 1 article reviews
stranded total rna plus ribo-zero kits - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

95
Norgen Biotek rna dna protein purification plus micro kit
Representative immunohistochemistry of galectin-3 protein expression in hearts (×200). (A) Sham. (B) BDL. (C) BDL+N-Lac. (D) Spleen was used as positive control. (A) Scant staining is visible in cardiomyocytes. (B) Significantly increased galectin-3 staining is predominantly in cardiomyocyte cytoplasm, although a few macrophages also stain. (C) N-Lac significantly decreased galectin-3 staining in BDL heart. N-Lac did not affect galectin-3 postive staining in heart from sham operated controls (data not shown). (D) Spleen shows expected heavy galectin-3 staining, as a positive control. Sham, sham operated; BDL, bile duct ligation; N-Lac, N <t>-acetyllactosamine.</t>
Rna Dna Protein Purification Plus Micro Kit, supplied by Norgen Biotek, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rna dna protein purification plus micro kit/product/Norgen Biotek
Average 95 stars, based on 1 article reviews
rna dna protein purification plus micro kit - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
Millipore carbidopa
Representative immunohistochemistry of galectin-3 protein expression in hearts (×200). (A) Sham. (B) BDL. (C) BDL+N-Lac. (D) Spleen was used as positive control. (A) Scant staining is visible in cardiomyocytes. (B) Significantly increased galectin-3 staining is predominantly in cardiomyocyte cytoplasm, although a few macrophages also stain. (C) N-Lac significantly decreased galectin-3 staining in BDL heart. N-Lac did not affect galectin-3 postive staining in heart from sham operated controls (data not shown). (D) Spleen shows expected heavy galectin-3 staining, as a positive control. Sham, sham operated; BDL, bile duct ligation; N-Lac, N <t>-acetyllactosamine.</t>
Carbidopa, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/carbidopa/product/Millipore
Average 90 stars, based on 1 article reviews
carbidopa - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Illumina Inc stranded total rna prep ligation with ribo-zero plus kit
Representative immunohistochemistry of galectin-3 protein expression in hearts (×200). (A) Sham. (B) BDL. (C) BDL+N-Lac. (D) Spleen was used as positive control. (A) Scant staining is visible in cardiomyocytes. (B) Significantly increased galectin-3 staining is predominantly in cardiomyocyte cytoplasm, although a few macrophages also stain. (C) N-Lac significantly decreased galectin-3 staining in BDL heart. N-Lac did not affect galectin-3 postive staining in heart from sham operated controls (data not shown). (D) Spleen shows expected heavy galectin-3 staining, as a positive control. Sham, sham operated; BDL, bile duct ligation; N-Lac, N <t>-acetyllactosamine.</t>
Stranded Total Rna Prep Ligation With Ribo Zero Plus Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stranded total rna prep ligation with ribo-zero plus kit/product/Illumina Inc
Average 90 stars, based on 1 article reviews
stranded total rna prep ligation with ribo-zero plus kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dawley Inc 6-mo-old female sprague-dawley rats
Representative immunohistochemistry of galectin-3 protein expression in hearts (×200). (A) Sham. (B) BDL. (C) BDL+N-Lac. (D) Spleen was used as positive control. (A) Scant staining is visible in cardiomyocytes. (B) Significantly increased galectin-3 staining is predominantly in cardiomyocyte cytoplasm, although a few macrophages also stain. (C) N-Lac significantly decreased galectin-3 staining in BDL heart. N-Lac did not affect galectin-3 postive staining in heart from sham operated controls (data not shown). (D) Spleen shows expected heavy galectin-3 staining, as a positive control. Sham, sham operated; BDL, bile duct ligation; N-Lac, N <t>-acetyllactosamine.</t>
6 Mo Old Female Sprague Dawley Rats, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/6-mo-old female sprague-dawley rats/product/Dawley Inc
Average 90 stars, based on 1 article reviews
6-mo-old female sprague-dawley rats - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Representative immunohistochemistry of galectin-3 protein expression in hearts (×200). (A) Sham. (B) BDL. (C) BDL+N-Lac. (D) Spleen was used as positive control. (A) Scant staining is visible in cardiomyocytes. (B) Significantly increased galectin-3 staining is predominantly in cardiomyocyte cytoplasm, although a few macrophages also stain. (C) N-Lac significantly decreased galectin-3 staining in BDL heart. N-Lac did not affect galectin-3 postive staining in heart from sham operated controls (data not shown). (D) Spleen shows expected heavy galectin-3 staining, as a positive control. Sham, sham operated; BDL, bile duct ligation; N-Lac, N -acetyllactosamine.

Journal: Clinical and Molecular Hepatology

Article Title: Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats

doi: 10.3350/cmh.2021.0141

Figure Lengend Snippet: Representative immunohistochemistry of galectin-3 protein expression in hearts (×200). (A) Sham. (B) BDL. (C) BDL+N-Lac. (D) Spleen was used as positive control. (A) Scant staining is visible in cardiomyocytes. (B) Significantly increased galectin-3 staining is predominantly in cardiomyocyte cytoplasm, although a few macrophages also stain. (C) N-Lac significantly decreased galectin-3 staining in BDL heart. N-Lac did not affect galectin-3 postive staining in heart from sham operated controls (data not shown). (D) Spleen shows expected heavy galectin-3 staining, as a positive control. Sham, sham operated; BDL, bile duct ligation; N-Lac, N -acetyllactosamine.

Article Snippet: There were four groups in each set: sham operated and sham plus N -acetyllactosamine (N-Lac, a galectin-3 inhibitor; 5 mg/kg); bile duct ligated (BDL) and BDL plus N-Lac.

Techniques: Immunohistochemistry, Expressing, Positive Control, Staining, Ligation

(A) Representative Western blot analysis of galectin-3 protein expression in hearts. From left, 1st and 2nd lanes, sham-operated controls; 3rd and 4th lanes, sham+N-Lac, 5th and 6th lanes, BDL, 7th and 8th lanes, BDL+N-Lac. (B) Computerized optical densitometry showed that galectin-3 protein expression was significant increased in BDL heart, N-Lac significantly decreased galectin-3 protein expression in BDL, N-Lac did not affect galectin-3 protein expression in sham operated rats (n=6 in each group, * P <0.01 compared with sham; † P <0.01 compared with BDL). Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Journal: Clinical and Molecular Hepatology

Article Title: Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats

doi: 10.3350/cmh.2021.0141

Figure Lengend Snippet: (A) Representative Western blot analysis of galectin-3 protein expression in hearts. From left, 1st and 2nd lanes, sham-operated controls; 3rd and 4th lanes, sham+N-Lac, 5th and 6th lanes, BDL, 7th and 8th lanes, BDL+N-Lac. (B) Computerized optical densitometry showed that galectin-3 protein expression was significant increased in BDL heart, N-Lac significantly decreased galectin-3 protein expression in BDL, N-Lac did not affect galectin-3 protein expression in sham operated rats (n=6 in each group, * P <0.01 compared with sham; † P <0.01 compared with BDL). Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Article Snippet: There were four groups in each set: sham operated and sham plus N -acetyllactosamine (N-Lac, a galectin-3 inhibitor; 5 mg/kg); bile duct ligated (BDL) and BDL plus N-Lac.

Techniques: Western Blot, Expressing, Ligation

(A) Representative Western blot analysis of collagen I/III protein expressions in hearts. From left, 1st and 2nd lanes, sham-operated controls; 3rd and 4th lanes, sham+N-Lac, 5th and 6th lanes, BDL, 7th and 8th lanes, BDL+N-Lac. (B) Computerized optical densitometry showed that the ratio of collagen I/III was shifted from collagen III dominant to collagen I dominant in BDL heart, N-Lac had the tendency to decrease the ratio of collagen I/III in cirrhotic heart (n=6 in each group, * P <0.01 compared with sham). Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Journal: Clinical and Molecular Hepatology

Article Title: Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats

doi: 10.3350/cmh.2021.0141

Figure Lengend Snippet: (A) Representative Western blot analysis of collagen I/III protein expressions in hearts. From left, 1st and 2nd lanes, sham-operated controls; 3rd and 4th lanes, sham+N-Lac, 5th and 6th lanes, BDL, 7th and 8th lanes, BDL+N-Lac. (B) Computerized optical densitometry showed that the ratio of collagen I/III was shifted from collagen III dominant to collagen I dominant in BDL heart, N-Lac had the tendency to decrease the ratio of collagen I/III in cirrhotic heart (n=6 in each group, * P <0.01 compared with sham). Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Article Snippet: There were four groups in each set: sham operated and sham plus N -acetyllactosamine (N-Lac, a galectin-3 inhibitor; 5 mg/kg); bile duct ligated (BDL) and BDL plus N-Lac.

Techniques: Western Blot, Ligation

The concentrations of TNFα in serum (A) and heart (B). From left, 1st and 2nd lanes, sham-operated controls; 3rd and 4th lanes, sham+N-Lac, 5th and 6th lanes, BDL, 7th and 8th lanes, BDL+N-Lac. The concentrations of TNFα in serum and heart were significantly increased in BDL, N-Lac significantly decreased TNFα concentrations in both serum and heart from cirrhotic rats (n=6 in each group, * P <0.01 compared with sham; † P <0.01 compared with BDL). TNFα, tumor necrosis factor alpha; Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Journal: Clinical and Molecular Hepatology

Article Title: Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats

doi: 10.3350/cmh.2021.0141

Figure Lengend Snippet: The concentrations of TNFα in serum (A) and heart (B). From left, 1st and 2nd lanes, sham-operated controls; 3rd and 4th lanes, sham+N-Lac, 5th and 6th lanes, BDL, 7th and 8th lanes, BDL+N-Lac. The concentrations of TNFα in serum and heart were significantly increased in BDL, N-Lac significantly decreased TNFα concentrations in both serum and heart from cirrhotic rats (n=6 in each group, * P <0.01 compared with sham; † P <0.01 compared with BDL). TNFα, tumor necrosis factor alpha; Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Article Snippet: There were four groups in each set: sham operated and sham plus N -acetyllactosamine (N-Lac, a galectin-3 inhibitor; 5 mg/kg); bile duct ligated (BDL) and BDL plus N-Lac.

Techniques: Ligation

The concentrations of BNP in serum (A) and heart (B). The concentrations of BNP in serum and heart were significantly increased in BDL rats. N-Lac significantly decreased BNP concentrations in both serum and heart from cirrhotic rats (n=6 in each group, * P <0.05 compared with sham; † P <0.05 compared with BDL). Sham, sham operated; BNP, brain natriuretic peptide; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Journal: Clinical and Molecular Hepatology

Article Title: Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats

doi: 10.3350/cmh.2021.0141

Figure Lengend Snippet: The concentrations of BNP in serum (A) and heart (B). The concentrations of BNP in serum and heart were significantly increased in BDL rats. N-Lac significantly decreased BNP concentrations in both serum and heart from cirrhotic rats (n=6 in each group, * P <0.05 compared with sham; † P <0.05 compared with BDL). Sham, sham operated; BNP, brain natriuretic peptide; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Article Snippet: There were four groups in each set: sham operated and sham plus N -acetyllactosamine (N-Lac, a galectin-3 inhibitor; 5 mg/kg); bile duct ligated (BDL) and BDL plus N-Lac.

Techniques: Ligation

(A) Isoproterenol-stimulated maximal systolic velocity in isolated cardiomyocytes. Systolic velocity was significantly decreased in cirrhotic rats compared to the sham control group ( P <0.05). Treatment of the cirrhotic group with N-Lac significantly reversed the reduced systolic contractility in BDL rats ( † P <0.05 compared to the BDL group) (n=6 in each group). (B) Time to peak 50% under stimulation of isoproterenol. Time to peak 50% was significantly prolonged in BDL cardiomyocytes compared with sham control ( * P <0.01), N-Lac reversed this delayed time to peak 50% ( † P <0.05 compared with untreated BDL), N-Lac had no effects on sham control group (n=6 in each group). Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Journal: Clinical and Molecular Hepatology

Article Title: Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats

doi: 10.3350/cmh.2021.0141

Figure Lengend Snippet: (A) Isoproterenol-stimulated maximal systolic velocity in isolated cardiomyocytes. Systolic velocity was significantly decreased in cirrhotic rats compared to the sham control group ( P <0.05). Treatment of the cirrhotic group with N-Lac significantly reversed the reduced systolic contractility in BDL rats ( † P <0.05 compared to the BDL group) (n=6 in each group). (B) Time to peak 50% under stimulation of isoproterenol. Time to peak 50% was significantly prolonged in BDL cardiomyocytes compared with sham control ( * P <0.01), N-Lac reversed this delayed time to peak 50% ( † P <0.05 compared with untreated BDL), N-Lac had no effects on sham control group (n=6 in each group). Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Article Snippet: There were four groups in each set: sham operated and sham plus N -acetyllactosamine (N-Lac, a galectin-3 inhibitor; 5 mg/kg); bile duct ligated (BDL) and BDL plus N-Lac.

Techniques: Isolation, Control, Ligation

(A) Diatolic relaxation velocity in isolated cardiomyocytes under the environment of isoproterenol stimulation. Diatolic relaxation velocity was significantly decreased in cirrhotic rats compared to the sham control group ( P <0.01). Treatment of the cirrhotic group with N-Lac significantly reversed the reduced diatolic relaxation velocity in BDL rats († P <0.05 compared to the BDL group) (n=6 in each group). (B) Time from peak contractility to 50% baseline under stimulation of isoproterenol was significantly prolonged in BDL cardiomyocytes compared with sham control ( * P <0.01), N-Lac reversed this delayed time ( † P <0.05 compared with untreated BDL), N-Lac had no effects on sham control group (n=6 in each group). Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Journal: Clinical and Molecular Hepatology

Article Title: Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats

doi: 10.3350/cmh.2021.0141

Figure Lengend Snippet: (A) Diatolic relaxation velocity in isolated cardiomyocytes under the environment of isoproterenol stimulation. Diatolic relaxation velocity was significantly decreased in cirrhotic rats compared to the sham control group ( P <0.01). Treatment of the cirrhotic group with N-Lac significantly reversed the reduced diatolic relaxation velocity in BDL rats († P <0.05 compared to the BDL group) (n=6 in each group). (B) Time from peak contractility to 50% baseline under stimulation of isoproterenol was significantly prolonged in BDL cardiomyocytes compared with sham control ( * P <0.01), N-Lac reversed this delayed time ( † P <0.05 compared with untreated BDL), N-Lac had no effects on sham control group (n=6 in each group). Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation.

Article Snippet: There were four groups in each set: sham operated and sham plus N -acetyllactosamine (N-Lac, a galectin-3 inhibitor; 5 mg/kg); bile duct ligated (BDL) and BDL plus N-Lac.

Techniques: Isolation, Control, Ligation

Blood pressure changes. The blood pressure was significantly decreased in cirrhotic rats, N-Lac significantly increased blood pressure in BDL rats. N-Lac had no effect on blood pressure in sham rats. The two measurements had no significant difference in BDL rats (n=6 in each group, * P <0.05 compared with other three groups). Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation. † Sham: 101±9.5 mmHg, Sham+N-Lac: 103±8.9 mmHg, BDL: 85.5±7.8 mmHg, BDL+N-Lac: 97.0±10.1 mmHg.

Journal: Clinical and Molecular Hepatology

Article Title: Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats

doi: 10.3350/cmh.2021.0141

Figure Lengend Snippet: Blood pressure changes. The blood pressure was significantly decreased in cirrhotic rats, N-Lac significantly increased blood pressure in BDL rats. N-Lac had no effect on blood pressure in sham rats. The two measurements had no significant difference in BDL rats (n=6 in each group, * P <0.05 compared with other three groups). Sham, sham operated; N-Lac, N -acetyllactosamine; BDL, bile duct ligation. † Sham: 101±9.5 mmHg, Sham+N-Lac: 103±8.9 mmHg, BDL: 85.5±7.8 mmHg, BDL+N-Lac: 97.0±10.1 mmHg.

Article Snippet: There were four groups in each set: sham operated and sham plus N -acetyllactosamine (N-Lac, a galectin-3 inhibitor; 5 mg/kg); bile duct ligated (BDL) and BDL plus N-Lac.

Techniques: Ligation